» Articles » PMID: 29534447

Selenides and Diselenides: A Review of Their Anticancer and Chemopreventive Activity

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2018 Mar 15
PMID 29534447
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Selenium and selenocompounds have attracted the attention and the efforts of scientists worldwide due to their promising potential applications in cancer prevention and/or treatment. Different organic selenocompounds, with diverse functional groups that contain selenium, have been reported to exhibit anticancer and/or chemopreventive activity. Among them, selenocyanates, selenoureas, selenoesters, selenium-containing heterocycles, selenium nanoparticles, selenides and diselenides have been considered in the search for efficiency in prevention and treatment of cancer and other related diseases. In this review, we focus our attention on the potential applications of selenides and diselenides in cancer prevention and treatment that have been reported so far. The around 80 selenides and diselenides selected herein as representative compounds include promising antioxidant, prooxidant, redox-modulating, chemopreventive, anticancer, cytotoxic and radioprotective compounds, among other activities. The aim of this work is to highlight the possibilities that these novel organic selenocompounds can offer in an effort to contribute to inspire medicinal chemists in their search of new promising derivatives.

Citing Articles

[Tc(NO)Cl(PPh)(CHCN)] and Its Reactions with 2,2'-Dipyridyl Dichalcogenides.

Sawallisch T, Rupf S, Abdulkader A, Ernst M, Roca Jungfer M, Abram U Molecules. 2025; 30(4).

PMID: 40005103 PMC: 11858252. DOI: 10.3390/molecules30040793.


Mechanism-Based Inhibition of Histone Deacetylase 6 by a Selenocyanate is Subject to Redox Modulation.

Christianson D, Czarnecki B, Goulart Stollmaier J, Czarnecki B bioRxiv. 2025; .

PMID: 39803514 PMC: 11722227. DOI: 10.1101/2025.01.04.631333.


Diethyl nitrosamine-induces neurobehavioral deficit, oxido-nitrosative stress in rats' brain: a neuroprotective role of diphenyl diselenide.

Owumi S, Chimezie J, Emmanuel P, Okeibuno A, Owoeye O BMC Neurosci. 2024; 25(1):77.

PMID: 39722026 PMC: 11669237. DOI: 10.1186/s12868-024-00922-8.


SLL-1A-16 suppresses proliferation and induces autophagy in non-small-cell lung cancer cells the AKT/mTOR signaling pathway.

Luo X, Wang J, Wang R, Lian J, Guo M, Zhou H RSC Med Chem. 2024; .

PMID: 39246748 PMC: 11376208. DOI: 10.1039/d4md00405a.


Di- and Triselenoesters-Promising Drug Candidates for the Future Therapy of Triple-Negative Breast Cancer.

Radomska D, Czarnomysy R, Szymanowska A, Radomski D, Chalecka M, Surazynski A Int J Mol Sci. 2024; 25(14).

PMID: 39063006 PMC: 11277004. DOI: 10.3390/ijms25147764.


References
1.
Plano D, Ibanez E, Calvo A, Antonio Palop J, Sanmartin C . Novel library of selenocompounds as kinase modulators. Molecules. 2011; 16(8):6349-64. PMC: 6264252. DOI: 10.3390/molecules16086349. View

2.
Tanaka T, Reddy B, El-Bayoumy K . Inhibition by dietary organoselenium, p-methoxybenzene-selenol, of hepatocarcinogenesis induced by azoxymethane in rats. Jpn J Cancer Res. 1985; 76(6):462-7. View

3.
Straliotto M, Hort M, Fiuza B, Rocha J, Farina M, Chiabrando G . Diphenyl diselenide modulates oxLDL-induced cytotoxicity in macrophage by improving the redox signaling. Biochimie. 2013; 95(8):1544-51. DOI: 10.1016/j.biochi.2013.04.008. View

4.
da Silva Machado M, Villela I, Moura D, Rosa R, Salvador M, Lopes N . 3'3-ditrifluoromethyldiphenyl diselenide: a new organoselenium compound with interesting antigenotoxic and antimutagenic activities. Mutat Res. 2009; 673(2):133-40. DOI: 10.1016/j.mrgentox.2009.01.003. View

5.
Manikova D, Letavayova L, Vlasakova D, Kosik P, Estevam E, Nasim M . Intracellular diagnostics: hunting for the mode of action of redox-modulating selenium compounds in selected model systems. Molecules. 2014; 19(8):12258-79. PMC: 6271387. DOI: 10.3390/molecules190812258. View